Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East
All India
COA
Product Description
It is recommended for use as a replacement for an ACE inhibitor or an angiotensin receptor blocker in people with heart failure with reduced ejection fraction.